A study of the effect of a single neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; "ecstasy") on the subsequent long-term behaviour of rats in the plus maze and open field

被引:52
作者
Mechan, AO
Moran, PM
Elliott, JM
Young, AMJ
Joseph, MH
Green, AR [1 ]
机构
[1] AstraZeneca R&D Charnwood, Loughborough LE11 5RH, Leics, England
[2] De Montfort Univ, Dept Pharmacol, Sch Pharm, Leicester LE1 9BH, Leics, England
[3] Univ Leicester, Sch Psychol, Leicester LE1 7RH, Leics, England
关键词
3,4-methylenedioxymethamphetarnine; MDMA; ecstasy; anxiety-related behaviour; elevated plus-maze; open field; long-term neurotoxicity;
D O I
10.1007/s002130100900
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rationale: Decreased 5-HT function has been shown to induce behaviour consistent with an "anxiolytic" effect. Administration of a single dose of 3,4-methylenedioxymethamphetamine (MDMA; "ecstasy" 12.5 mg/kg IP) to rats results in prolonged damage to central serotonergic nerve terminals. Thus we wished to assess whether an MDMA-induced lesion may have longer-term behavioural consequences. Objective: The study was designed to examine the behaviour of MDMA-pretreated and control animals in the elevated plus-maze and open field at a number of time-points, up to 80 days, after the administration of a single neurotoxic dose of MDMA (12.5 mg/kg IP). Results: MDMA-pretreated Dark Agouti rats demonstrated a statistically significant reduction in anxiety-related behaviour, compared to saline-pretreated control rats, in both the elevated plus-maze and open field when the rats were tested on day 73 (open field) and day 80 (plus maze) after MDMA administration. Conclusions: The behavioural consequences of a single neurotoxic dose of MDMA can be demonstrated over 2 months after administration of the compound, thereby indicating that long-term adaptive changes occur within the brain following the neurodegeneration of 5-HT neurones produced by this recreationally used drug.
引用
收藏
页码:167 / 175
页数:9
相关论文
共 71 条
[21]   Androgen actions on central serotonin neurotransmission: relevance for mood, mental state and memory [J].
Fink, G ;
Sumner, B ;
Rosie, R ;
Wilson, H ;
McQueen, J .
BEHAVIOURAL BRAIN RESEARCH, 1999, 105 (01) :53-68
[22]   Mood state and brain electric activity in Ecstasy users [J].
Gamma, A ;
Frei, E ;
Lehmann, D ;
Pascual-Marqui, RD ;
Hell, D ;
Vollenweider, FX .
NEUROREPORT, 2000, 11 (01) :157-162
[23]   EFFECTS OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE ON AUTONOMIC THERMOREGULATORY RESPONSES OF THE RAT [J].
GORDON, CJ ;
WATKINSON, WP ;
OCALLAGHAN, JP ;
MILLER, DB .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1991, 38 (02) :339-344
[24]   REVIEW OF THE PHARMACOLOGY AND CLINICAL-PHARMACOLOGY OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA OR ECSTASY) [J].
GREEN, AR ;
CROSS, AJ ;
GOODWIN, GM .
PSYCHOPHARMACOLOGY, 1995, 119 (03) :247-260
[25]   Ecstasy and neurodegeneration - Ecstasy's long term effects are potentially more damaging than its acute toxicity [J].
Green, AR ;
Goodwin, GM .
BRITISH MEDICAL JOURNAL, 1996, 312 (7045) :1493-1494
[26]   Risk assessment behaviour: Evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test [J].
Griebel, G ;
Rodgers, RJ ;
Perrault, G ;
Sanger, DJ .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1997, 57 (04) :817-827
[27]   5HT DRUGS IN ANIMAL-MODELS OF ANXIETY [J].
HANDLEY, SL ;
MCBLANE, JW .
PSYCHOPHARMACOLOGY, 1993, 112 (01) :13-20
[28]   MULTIPLE SEROTONIN MECHANISMS IN ANIMAL-MODELS OF ANXIETY - ENVIRONMENTAL, EMOTIONAL AND COGNITIVE-FACTORS [J].
HANDLEY, SL ;
MCBLANE, JW ;
CRITCHLEY, MAE ;
NJUNGE, K .
BEHAVIOURAL BRAIN RESEARCH, 1993, 58 (1-2) :203-210
[29]   TOXICITY AND DEATHS FROM 3,4-METHYLENEDIOXYMETHAMPHETAMINE (ECSTASY) [J].
HENRY, JA ;
JEFFREYS, KJ ;
DAWLING, S .
LANCET, 1992, 340 (8816) :384-387
[30]   Responses of Swiss-Webster mice to repeated plus-maze experience: Further evidence for a qualitative shift in emotional state? [J].
Holmes, A ;
Rodgers, RJ .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1998, 60 (02) :473-488